IP Library › Granted Patent US 12,458,799
Granted Patent B2
US 12,458,799 · App. 17/571,924 · Granted Nov 4, 2025

Attenuation arrangement for implantable medical device

Inventors: Kevin Verzal (Lino Lakes, MN); John Rondoni (Plymouth, MN); David Dieken (Minneapolis, MN)
Assignee: Inspire Medical Systems, Inc.
A61N1/086A61N1/05A61N1/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,458,799
App. No.
17/571,924
Granted
Nov 4, 2025
Kind
B2
Abstract

An implantable medical device includes at least one conductive element and an associated attenuation arrangement to attenuate MRI energy.

Claims (30)

1 . An implantable device comprising:

a cuff electrode at least partially self-wrappable about a nerve, the cuff electrode including:

a flexible printed electronic assembly including:

a first printed signal conductive element printed onto a first side of a base layer,

a first printed insulator layer printed over the first printed signal conductive element opposite the first side of the base layer,

a second printed signal conductive element printed onto a second side of the base insulator such that the base layer is interposed between the first and second printed signal conductive elements,

a printed conductive shield at least partially surrounding at least one of the first and second printed conductive elements; and

a first contact electrode electrically coupled to the first printed signal conductive element.

2 . The implantable device of claim 1 , wherein the flexible printed electronic assembly is shaped to define a cuff body that is at least partially self-wrappable about a nerve.

3 . The implantable device of claim 1 , wherein the cuff electrode further includes a cuff body carrying the flexible printed electronic assembly.

4 . The implantable device of claim 1 , wherein the first contact electrode is integrally formed as part of the flexible printed electronic assembly.

5 . The implantable device of claim 1 , wherein the first contact electrode is mounted to the flexible printed electronic assembly.

6 . The implantable device of claim 1 , wherein the flexible printed electronic assembly further includes a printed outer insulator layer, and further wherein at least a portion of the first contact electrode is embedded into a thickness of the printed outer insulator layer.

7 . The implantable device of claim 1 , wherein the flexible printed electronic assembly further includes a printed outer insulator layer supporting the first contact electrode and a first printed via, the first printed via being printed onto and extending from the first printed signal conductive element through a thickness of the printed outer insulator layer.

8 . The implantable device of claim 1 , wherein the flexible printed circuit assembly further comprises:

a second printed insulator layer printed over the second printed signal conductive element opposite the base layer.

9 . The implantable device of claim 8 , wherein the printed conductive shield comprises the flexible printed circuit assembly including a first printed shield conductive element printed over the first printed insulator layer and a second printed shield conductive element printed over the second printed insulator layer.

10 . The implantable device of claim 9 , wherein the flexible printed circuit assembly further includes a third printed insulator layer printed over the first printed shield conductive element and a fourth printed insulator layer printed over the second printed shield conductive element.

11 . The implantable device of claim 1 , wherein the flexible printed electronic assembly further includes an attenuation arrangement to attenuate MRI-energy.

12 . The implantable device of claim 11 , wherein the attenuation arrangement comprises at least one of a filter, a shield, and an anti-phase arrangement.

13 . The implantable medical device of claim 11 , wherein the attenuation arrangement is a printed component of the flexible printed circuit assembly, the printed attenuation arrangement being printed relative to the base layer.

14 . The implantable device of claim 1 , wherein the cuff electrode further comprises an array of contact electrodes, the array including the first contact electrode.

15 . The implantable device of claim 14 , wherein the cuff electrode defines opposing ends, and further wherein the array of contact electrodes includes at least one of:

a plurality of electrodes longitudinally spaced apart between the opposing ends, and

a plurality of electrodes spaced apart in a circumferential pattern.

16 . The implantable device of claim 15 , wherein the flexible printed circuit assembly includes a plurality of printed signal conductive elements corresponding to the plurality of electrodes.

17 . The implantable device of claim 16 , wherein each of the printed signal conductive elements are electrically isolated from one another within the flexible printed circuit assembly.

18 . The implantable device of claim 16 , wherein the cuff electrode further includes a cuff body carrying the flexible printed circuit assembly, the cuff body forming an internal surface defining a lumen for receiving a nerve, an external surface opposite the internal surface, and a first resilient arm opposite a second resilient arm, wherein the first resilient arm terminates at a first end and the second resilient arm terminates at a second end, and even further wherein a contour of the external surface from the first end to the second end is generally uniform.

19 . The implantable device of claim 1 , further comprising a lead extending from the cuff electrode.

20 . The implantable device of claim 19 , wherein the flexible printed circuit assembly defines at least a portion of the lead.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2022
From: VERZAL, KEVIN; RONDONI, JOHN; DIEKEN, DAVID
To: INSPIRE MEDICAL SYSTEMS, INC.
Reel/Frame 058603/0943 →
Continuity (3)
Continuation 16092387
Provisional Application 62334774 · May 11, 2016
Related Publication 20220126092A1 · Apr 28, 2022
References Cited (92)
US 3572322A · Wade · 1971 [cited by applicant]
US 4461304A · Kuperstein · 1984 [cited by applicant]
US 4735208A · Wyler et al. · 1988 [cited by applicant]
US 4785672A · Picone · 1988 [cited by applicant]
US 4869255A · Putz · 1989 [cited by applicant]
US 5493074A · Murata et al. · 1996 [cited by applicant]
US 5569886A · Tanabe et al. · 1996 [cited by applicant]
US 6024702A · Iversen · 2000 [cited by applicant]
US 6624510B1 · Chan et al. · 2003 [cited by applicant]
US 6944489B2 · Zeijlemaker · 2005 [cited by applicant]
US 6985775B2 · Reinke et al. · 2006 [cited by applicant]
US 7369898B1 · Kroll et al. · 2008 [cited by applicant]
US 7383090B2 · O'Brien et al. · 2008 [cited by applicant]
US 7509167B2 · Stressman · 2009 [cited by applicant]
US 7561915B1 · Cooke et al. · 2009 [cited by applicant]
US 7844319B2 · Susil et al. · 2010 [cited by applicant]
US 7877150B2 · Hoegh et al. · 2011 [cited by applicant]
US 8014867B2 · Cooke et al. · 2011 [cited by applicant]
US 8032230B1 · Cox et al. · 2011 [cited by applicant]
US 8055351B2 · Atalar et al. · 2011 [cited by applicant]
US 8200334B1 · Min et al. · 2012 [cited by applicant]
US 8364286B2 · Hoegh et al. · 2013 [cited by applicant]
US 8412351B2 · Zeijlemaker et al. · 2013 [cited by applicant]
US 8521254B2 · Doerr et al. · 2013 [cited by applicant]
US 8527046B2 · Connelley et al. · 2013 [cited by applicant]
US 8606365B2 · Sison · 2013 [cited by applicant]
US 8620454B2 · Wahlstrand et al. · 2013 [cited by applicant]
US 8761899B2 · Lloyd et al. · 2014 [cited by applicant]
US 8761900B2 · Lloyd et al. · 2014 [cited by applicant]
US 8805540B2 · Lloyd et al. · 2014 [cited by applicant]
US 8831743B2 · Lloyd et al. · 2014 [cited by applicant]
US 8843212B2 · Lloyd et al. · 2014 [cited by applicant]
US 8843213B2 · Lloyd et al. · 2014 [cited by applicant]
US 8868208B2 · Seifert · 2014 [cited by applicant]
US 8996126B2 · Stevenson et al. · 2015 [cited by applicant]
US 8996134B2 · Duncan et al. · 2015 [cited by applicant]
US 9020610B2 · Zeijlemaker · 2015 [cited by applicant]
US 9089695B2 · Seifert et al. · 2015 [cited by applicant]
US 9226688B2 · Jacobsen et al. · 2016 [cited by applicant]
US 9226689B2 · Jacobsen et al. · 2016 [cited by applicant]
US 9226800B2 · Burg et al. · 2016 [cited by applicant]
US 9232985B2 · Jacobsen et al. · 2016 [cited by applicant]
US 9242090B2 · Atalar et al. · 2016 [cited by applicant]
US 9420953B2 · Litt et al. · 2016 [cited by applicant]
US 9450043B2 · Nuzzo et al. · 2016 [cited by applicant]
US 10183166B2 · Gururaj et al. · 2019 [cited by applicant]
US 10524681B2 · Decre et al. · 2020 [cited by applicant]
US 11118965B2 · Rogers et al. · 2021 [cited by applicant]
US 20030144718A1 · Zeijlemaker · 2003 [cited by applicant]
US 20030144719A1 · Zeijlemaker · 2003 [cited by applicant]
US 20040111139A1 · McCreery · 2004 [cited by examiner]
US 20040176831A1 · Gliner et al. · 2004 [cited by applicant]
US 20040230114A1 · Clatterbaugh et al. · 2004 [cited by applicant]
US 20050065587A1 · Gryzwa · 2005 [cited by applicant]
US 20050070972A1 · Wahlstrand et al. · 2005 [cited by applicant]
US 20050222658A1 · Hoegh et al. · 2005 [cited by applicant]
US 20060200218A1 · Wahlstrand · 2006 [cited by examiner]
US 20060247747A1 · Olsen et al. · 2006 [cited by applicant]
US 20060293591A1 · Wahstrand · 2006 [cited by applicant]
US 20070088416A1 · Atalar et al. · 2007 [cited by applicant]
US 20070112398A1 · Stevenson et al. · 2007 [cited by applicant]
US 20080119919A1 · Atalar et al. · 2008 [cited by applicant]
US 20080243218A1 · Bottomley et al. · 2008 [cited by applicant]
US 20080269831A1 · Erickson · 2008 [cited by applicant]
US 20100094364A1 · McDonald · 2010 [cited by applicant]
US 20100106227A1 · Min et al. · 2010 [cited by applicant]
US 20100222844A1 · Troosters et al. · 2010 [cited by applicant]
US 20110015713A1 · Min · 2011 [cited by applicant]
US 20110029036A1 · Yamamoto et al. · 2011 [cited by applicant]
US 20110077708A1 · Ostroff · 2011 [cited by applicant]
US 20110152990A1 · Shehada et al. · 2011 [cited by applicant]
US 20110237921A1 · Askin, III · 2011 [cited by examiner]
US 20120078333A1 · Westlund et al. · 2012 [cited by applicant]
US 20120203100A1 · Weiss · 2012 [cited by examiner]
US 20120209365A1 · Seifert et al. · 2012 [cited by applicant]
US 20130018439A1 · Chow · 2013 [cited by examiner]
US 20140012130A1 · Jacobsen et al. · 2014 [cited by applicant]
US 20140113828A1 · Gilbert et al. · 2014 [cited by applicant]
US 20140114379A1 · Seifert et al. · 2014 [cited by applicant]
US 20140236255A1 · Meadows · 2014 [cited by examiner]
US 20140249597A1 · Fang · 2014 [cited by examiner]
US 20150031975A1 · Atalar et al. · 2015 [cited by applicant]
US 20150202433A1 · Franke · 2015 [cited by examiner]
US 20150207484A1 · Stevenson et al. · 2015 [cited by applicant]
US 20160331960A1 · Katnani et al. · 2016 [cited by applicant]
US 20170106186A1 · Thompson et al. · 2017 [cited by applicant]
WO 2011051872 · 2011 [cited by applicant]
Wonderful PCB Limited, Brief Classification of Flexible Printed Circuits (FPC), Source Tech 411, Dec. 3, 2013, 3 pages. [cited by applicant]
Bottomley et al., Designing passive MRI-save implantable conducting leads with electrodes, PubMed-NCBI, Jul. 2010, 1 page. [cited by applicant]
Gray et al., Simple design changes to wires to substantially reduce MRI-induced heating at 1.5T: implications for Implant leads, PubMed-NCBI, Oct. 2005, 1 page. [cited by applicant]
Bottomley PA , Kumar A, Edelstein WA, Allen JM, and Karmarkar PV, “Designing passive MRI-safe implantable conducting leads with electrodes,” Med Phys., vol. 37, No. 7, Jul. 2010, pp. 3828-3843. [cited by applicant]
Gray RW , Bibens WT, and Shellock FG, “Simple design changes to wires to substantially reduce MRI-induced heating at 1.5 T: implications for implanted leads,” Magn Reson Imaging, vol. 23, No. 8, Epub. Oct. 2005, pp. 887… [cited by applicant]